Diabetes journal: Quick facts and submission tips
Aims and Scope
American Diabetes Association
Frequency of publication
CRITERIA FOR PUBLICATION
- Diabetes does not accept studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus.
- Diabetes publishes: original articles, brief reports, perspectives and review articles, and supplemental Articles (considers two types of review articles: Methodological Reviews and Perspectives in Diabetes).
- All clinical trials submitted to Diabetes must be registered. Registries must be approved by ICJME. Approved registries include:
- Articles should be written following the recommendations for scientific writing found in Scientific Style and Format, the Council of Science Editors (CSE) style manual (7th ed.)
- Other guidelines around manuscript preparation can be found here: http://diabetes.diabetesjournals.org/content/instructions-for-authors
EDITORIAL POLICIES AND SUBMISSION GUIDELINES
- Publication Policies and Procedures are adopted from the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics.
- Manuscripts must be submitted online: http://mc.manuscriptcentral.com/diabetes.
- A Manuscript Submission Form must be completed for each article submitted. Submissions are incomplete until this form has been uploaded/received. The form can be downloaded from here:
- All submissions to the journal will be scanned for possible duplicate or prior publication using the CrossCheck/iThenticate plagiarism detection system (www.ithenticate.com/). Authors who submit previously published work to the journal will be banned from submitting future manuscripts to the journal, and their funding body and/or institution will be notified.
- For other detailed guidelines around study design, authorship, plagiarism, etc., visit this page: http://diabetes.diabetesjournals.org/site/misc/PoliciesDiabetes.pdf
- Diabetes requires reporting on HbA1c levels in both traditional, DCCT-derived units (as %) and SI, IFCC-recommended units (as mmol/mol). Authors are advised to use the NGSP converter for HbA1c, available at http://www.ngsp.org/convert1.asp, to calculate HbA1c values as both % and mmol/mol.
MANUSCRIPT REVIEW PROCESS
GOOD PUBLISHING PRACTICES
- Be sure to read through the Publication Policies and Procedures to take appropriate actions:
- The document contains information on the following:
- Study Design
- Originality and Prior Publication
- Authorship and Contributions
- Conflict of Interest
- Clinical Trials, Systematic Reviews, and Meta-Analyses
- Digital Image Manipulation
- Responses to Possible Scientific Misconduct
- Peer Review
- Editorial Decisions
- Prepublication of Accepted Articles
- Reuse, Post-Prints, and Public Access
- Media Embargos
ADDITIONAL LINKS SUGGESTED FOR AUTHORS
- For information on how to submit a review articles, see http://diabetes.diabetesjournals.org/site/misc/HowtoSubmitProposal_Diabetes.pdf
- Recommendations for the Conduct, Reporting, Editing, and
Publication of Scholarly Work in Medical Journals
- ADA's Policy Statement on Duality of Interest
- See “About the Journal” page of the online journal for Information on each journal’s acceptance rates, publication intervals, and other performance data
- Some podcasts on Diabetes articles or other ADA journals can be found here: http://www.diabetesjournals.org/content/diabetes-core-update-podcasts
- Impact factor: 7.895*
- Ranks #6 out of 121 journals in the category of “Endocrinology & Metabolism” *
- Acceptance rate: 34% for original articles and 19% for brief reports.
*Source: 2012 Journal Citation Reports® (Thomson Reuters, 2013)
You're looking to give wings to your academic career and publication journey. We like that!
Why don't we give you complete access! Create a free account and get unlimited access to all resources & a vibrant researcher community.